NeoGenomics director exercises RSUs, granted new options
NEOGENOMICS INC director Marjorie C. Green reported equity compensation activity and an option-related share issuance.
Rhea-AI Filing Summary
NEOGENOMICS INC director Marjorie C. Green reported equity compensation activity and an option-related share issuance. She exercised previously reported restricted stock units into 22,964 shares of common stock, which she now holds directly. She also received new awards of 15,970 restricted stock units scheduled to vest on June 1, 2027 and 11,069 stock options exercisable at $10.52 per share expiring on June 1, 2036. A separate option position covering 16,019 underlying shares at an exercise price of $6.95 per share remains outstanding and expires on June 19, 2035. The filing shows only grants and exercises, with no open‑market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
22,964 shares exercised/converted
Exercise
5 txns
Insider
Green Marjorie C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 22,964 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 11,069 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 15,970 | $0.00 | $0.00 |
| Exercise | Common Stock | 22,964 | $0.00 | $0.00 |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 15,970 contracts (Direct);
Stock Option (Right to Buy) — 27,088 contracts for 16,019 underlying shares (Direct);
Common Stock — 22,964 shares (Direct)
Footnotes (2)
- F1. Reflects release of restricted stock units that were previously reported on a Form 4.
- F2. Once vested, the shares of common stock are not subject to expiration.
Key Figures
RSUs exercised to common: 22,964 shares
Common shares held: 22,964 shares
New RSU grant: 15,970 units
+3 more
6 metrics
RSUs exercised to common
22,964 shares
Restricted stock units released into common stock on June 1, 2026
Common shares held
22,964 shares
Direct holdings after transactions
New RSU grant
15,970 units
Restricted stock units vesting June 1, 2027 at $0.00 conversion price
New option grant
11,069 options at $10.52
Stock options expiring June 1, 2036
Existing option position
16,019 underlying shares at $6.95
Stock option expiring June 19, 2035
Derivative exercises
22,964 shares
Total derivative shares exercised in this filing
Key Terms
Restricted Stock Unit, Stock Option (Right to Buy), Exercise or conversion of derivative security, Grant, award, or other acquisition
4 terms
Restricted Stock Unit financial
"Security title listed as "Restricted Stock Unit" in the transactions table."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (Right to Buy) financial
"Derivative security shown as "Stock Option (Right to Buy)" with exercise prices."
Exercise or conversion of derivative security financial
"Transaction code description states "Exercise or conversion of derivative security" for code M."
Grant, award, or other acquisition financial
"Transaction code description notes "Grant, award, or other acquisition" for new equity awards."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did NeoGenomics (NEO) director Marjorie Green report?
Marjorie Green reported equity compensation activity, not market trades. She exercised restricted stock units into 22,964 common shares and received new grants of 15,970 restricted stock units plus 11,069 stock options, all held directly as part of her director compensation.
What new equity awards did Marjorie Green receive from NeoGenomics (NEO)?
She received 15,970 restricted stock units and 11,069 stock options. The RSUs convert into common stock on June 1, 2027, while the options allow her to buy common shares at $10.52 per share until June 1, 2036, if she chooses to exercise.
What stock option positions does Marjorie Green have with NeoGenomics (NEO)?
She holds an existing option over 16,019 underlying shares at a $6.95 exercise price expiring June 19, 2035, plus a new option for 11,069 shares at a $10.52 exercise price expiring June 1, 2036, both tied to NeoGenomics common stock.
How many restricted stock units does Marjorie Green still hold in NeoGenomics (NEO)?
After exercising 22,964 previously reported units into common shares, she now holds 15,970 restricted stock units. These remaining units are scheduled to convert into NeoGenomics common stock on June 1, 2027, and carry a stated conversion price of $0.00.
AI-generated analysis. How Rhea-AI works. Not financial advice.
